Download presentation
Presentation is loading. Please wait.
1
Volume 74, Issue 4, Pages 455-462 (October 2018)
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial Shankar Siva, Mathias Bressel, Declan G. Murphy, Mark Shaw, Sarat Chander, John Violet, Keen Hun Tai, Cristian Udovicich, Andrew Lim, Lisa Selbie, Michael S. Hofman, Tomas Kron, Daniel Moon, Jeremy Goad, Nathan Lawrentschuk, Farshad Foroudi European Urology Volume 74, Issue 4, Pages (October 2018) DOI: /j.eururo Copyright © Terms and Conditions
2
Fig. 1 Survival. (A) Local progression-free survival and (B) distant progression-free survival. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
3
Fig. 2 Waterfall plot of maximal change in prostate-specific antigen (PSA) from baseline characterized by lesion type. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
4
Fig. 3 Patterns of failure based on disease location of oligometastases (nodal only versus bone only). One patient was excluded from this chart due to extra pelvic nodal disease only, and one further patient with mixed bone and nodal disease. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.